25,393 Shares of National Research Corporation $NRC Purchased by Integrity Alliance LLC.

Integrity Alliance LLC. purchased a new stake in National Research Corporation (NASDAQ:NRC) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 25,393 shares of the company’s stock, valued at approximately $538,000. Integrity Alliance LLC. owned approximately 0.11% of National Research as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Farmers & Merchants Investments Inc. grew its holdings in shares of National Research by 51.7% during the 3rd quarter. Farmers & Merchants Investments Inc. now owns 501,731 shares of the company’s stock worth $10,632,000 after purchasing an additional 171,082 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of National Research by 4.0% in the first quarter. Bank of New York Mellon Corp now owns 250,707 shares of the company’s stock valued at $4,257,000 after purchasing an additional 9,730 shares in the last quarter. Heartland Advisors Inc. raised its stake in shares of National Research by 374.3% in the first quarter. Heartland Advisors Inc. now owns 237,147 shares of the company’s stock valued at $4,027,000 after purchasing an additional 187,147 shares in the last quarter. Bank of America Corp DE lifted its position in National Research by 3.0% in the first quarter. Bank of America Corp DE now owns 112,468 shares of the company’s stock worth $1,910,000 after purchasing an additional 3,323 shares during the period. Finally, Fifth Third Bancorp bought a new position in National Research in the first quarter worth $1,531,000. Institutional investors own 47.26% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on NRC. Zacks Research upgraded shares of National Research to a “hold” rating in a research note on Monday, October 5th. Wall Street Zen upgraded shares of National Research from a “hold” rating to a “buy” rating in a research note on Saturday. Citizens Jmp increased their price objective on shares of National Research from $26.00 to $27.00 and gave the company a “market outperform” rating in a research note on Wednesday, October 28th. Finally, Weiss Ratings raised shares of National Research from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, October 28th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, National Research presently has an average rating of “Hold” and a consensus target price of $27.00.

National Research Trading Up 1.5%

NRC stock opened at $25.86 on Friday. National Research Corporation has a 1-year low of $11.73 and a 1-year high of $27.41. The firm has a market cap of $588.32 million, a P/E ratio of 92.36 and a beta of 0.22. The business’s 50 day moving average is $21.55 and its 200-day moving average is $19.30. The company has a current ratio of 0.64, a quick ratio of 0.65 and a debt-to-equity ratio of 13.13.

National Research (NASDAQ:NRC) last issued its earnings results on Tuesday, October 27th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.03. The business had revenue of $38.40 million during the quarter, compared to analysts’ expectations of $35.80 million. National Research had a return on equity of 313.25% and a net margin of 4.48%. Equities analysts anticipate that National Research Corporation will post 0.97 earnings per share for the current fiscal year.

National Research Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 8th. Shareholders of record on Tuesday, December 29th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 2.5%. The ex-dividend date is Tuesday, December 29th. National Research’s dividend payout ratio is currently 228.57%.

National Research Company Profile

National Research Corporation, formerly traded on the Nasdaq under the symbol NRC, provides research, analytics and performance-improvement services to the health care industry. Through its NRC Health business, the company helps hospitals, health systems and other care organizations understand and improve patient, consumer and employee experiences.

Its offerings have included patient and employee surveys, market research, reputation management, loyalty and engagement programs, benchmarking, and software tools that turn feedback and other data into operational insights.